Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 14, 2022
BioNTech announced its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific entered into an agreement with Novartis Singapore Pharmaceutical Manufacturing to acquire one of its GMP-certified manufacturing facilities. Supported by the Singapore ...
read more
Monday, November 14, 2022
Mural Health Technologies announced the launch of its new platform, Mural Link, built to make it easy to participate in global clinical research studies.
read more
Thursday, November 10, 2022
Celerion is expanding its molecular and cellular capabilities to Good Laboratory Practice/Good Clinical Practice (GLP/GCP) standards to support the development of new gene and cell therapies.
read more
Tuesday, November 08, 2022
Global Healthcare Opportunities, or GHO Capital Partners LLP and The Vistria Group announced that they have entered into a definitive agreement to acquire a controlling interest in Alcami Corporation from funds affiliated with Madison Dearborn ...
read more
Tuesday, November 08, 2022
Quanticate, a global data-focused clinical research organization (CRO), has announced plans for further expansion and new jobs in 2023 as it thrives post-pandemic.
read more
Tuesday, November 08, 2022
Insilico Medicine, a clinical stage artificial intelligence driven drug discovery company, announced a multi-year, multi-target strategic research collaboration with Sanofi. Under the terms of the agreement, the collaboration will leverage Insilico ...
read more
Monday, November 07, 2022
Charles River Laboratories International, Inc. announced the expansion of its cell therapy contract development and manufacturing (CDMO) facility in Memphis, Tenn. The expanded space is suitable for clinical and commercial cell therapy manufacturing,...
read more
Friday, November 04, 2022
Medmix Drug Delivery (Haselmeier) and AARDEX Group announced a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem.
read more
Friday, November 04, 2022
Wheeler Bio and CRB announced the start of construction on a GMP drug substance facility that will support innovators seeking agile, small batch manufacturing services for their clinical trial materials (CTM).
read more
Friday, November 04, 2022
QIAGEN Digital Insights (QDI), the bioinformatics business of QIAGEN, announced the launch of their new cell line database developed through its partnership with ATCC, a biological materials organization, developer and supplier of authenticated cell ...
read more
Friday, November 04, 2022
Exelixis, Inc. and Catalent, Inc. announced a new license agreement under which Catalent’s Redwood Bioscience subsidiary will grant Exelixis an exclusive license to three target programs with lead antibody and/or ADC candidates.
read more
Thursday, November 03, 2022
TFF Pharmaceuticals announced a collaboration with Aptar Pharma aimed at developing and testing the administration of dry powder vaccines utilizing TFF Pharmaceutical’s Thin Film Freezing technology and Aptar Pharma’s proprietary intranasal Unidose (...
read more
Thursday, November 03, 2022
Avantor has opened a new distribution center in Dublin, Ireland. The nearly 69,000-square-foot facility is the most advanced distribution center in Avantor's global network and places mission-critical products and operational support close to Avantor...
read more
Wednesday, November 02, 2022
First Wave BioPharma, Inc. announced that it has entered into an agreement with Rho, a full-service contract research organization (CRO), for its planned Phase 2 clinical trial of an enhanced enteric microgranule delivery formulation for adrulipase.
read more
Wednesday, November 02, 2022
Avirmax CMC Inc. has completed its brand-new facility in Hayward, CA (San Francisco Bay Area). The facility has received cGMP license approval by the California Department of Public Health (CDPH)-Food & Drug Branch, for the production of rAAV drug ...
read more